Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function

References

• Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90:1335–1345.
   PubMedGoogle Scholar
• van Bodegom PC, Wagenaar SS, Corrin B, et al. Second primary lung cancer: importance of long term follow up. Thorax. 1989;44:788–793.
   PubMed Web of Science ®Google Scholar
• Aziz TM, Saad RA, Glasser J, et al. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg. 2002;21:527–533.
   PubMed Web of Science ®Google Scholar
• Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–612.
   PubMed Web of Science ®Google Scholar
• Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630–637.
   PubMed Web of Science ®Google Scholar
• Stephans KL, Woody NM, Reddy CA, et al. Tumor control and toxicity for common stereotactic body radiation therapy dose-fractionation regimens in stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2018;100:462–469.
   PubMed Web of Science ®Google Scholar
• Mitsuyoshi T, Matsuo Y, Shintani T, et al. Pilot study of the safety and efficacy of dose escalation in stereotactic body radiotherapy for peripheral lung tumors. Clin Lung Cancer. 2018;19:e287–e296.
   PubMed Web of Science ®Google Scholar
• Baine MJ, Verma V, Schonewolf CA, et al. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer. Lung Cancer. 2018;118:20–26.
   PubMed Web of Science ®Google Scholar
• Olsen GN, Block AJ, Tobias JA. Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest. 1974;66:13–16.
   PubMed Web of Science ®Google Scholar
• Nakahara K, Monden Y, Ohno K, et al. 1985: a method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. 1992 update. Ann Thorac Surg. 1992;54:1016–1017.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(Suppl.1):1–232.
   PubMedGoogle Scholar
• Takeda A, Sanuki N, Eriguchi T, et al. Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer. Ann Thorac Surg. 2013;96:1776–1782.
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Kodama K, Teshima T, et al. Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer. Jpn J Clin Oncol. 2015;45:947–952.
   PubMed Web of Science ®Google Scholar
• Chang JY, Liu LH, Zhu Z, et al. Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer. Cancer. 2013;119:3402–3410.
   PubMed Web of Science ®Google Scholar
• Creach KM, Bradley JD, Mahasittiwat P, et al. Stereotactic body radiation therapy in the treatment of multiple primary lung cancers. Radiother Oncol. 2012;104:19–22.
   PubMed Web of Science ®Google Scholar
• Yukiue H, Tanahashi M, Haneda H, et al. [Surgical treatment for recurrent and second primary lung cancer]. Kyobu Geka. 2010;63:944–949 (Japanese).
   PubMedGoogle Scholar
• van Rens MT, Zanen P, de la Rivière AB, et al. Survival after resection of metachronous non-small cell lung cancer in 127 patients. Ann Thorac Surg. 2001;71:309–313.
   PubMed Web of Science ®Google Scholar
• Battafarano RJ, Force SD, Meyers BF, et al. Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg. 2004;127:836–842.
   PubMed Web of Science ®Google Scholar
• De Leyn P, Moons J, Vansteenkiste J, et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg. 2008;34:1215–1222.
   PubMed Web of Science ®Google Scholar
• Kocaturk CI, Gunluoglu MZ, Cansever L, et al. Survival and prognostic factors in surgically resected synchronous multiple primary lung cancers. Eur J Cardiothorac Surg. 2011;39:160–166.
   PubMed Web of Science ®Google Scholar
• Koezuka S, Hata Y, Otsuka H, et al. Metachronous second primary lung cancer surgically treated five years or more after the initial surgery. Mol Clin Oncol. 2015;3:1025–1028.
   PubMed Web of Science ®Google Scholar
• Mentzer SJ, Swanson SJ. Treatment of patients with lung cancer and severe emphysema. Chest. 1999;116(Suppl.6):477S–479S.
   Web of Science ®Google Scholar
• Kojima S, Sakakibara H, Motani S, et al. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol. 2015;15:113–117.
   Web of Science ®Google Scholar
• Ozawa Y, Abe T, Omae M, et al. Impact of preexisting interstitial lung disease on acute, extensive radiation pneumonitis: retrospective analysis of patients with lung cancer. PLoS One. 2015;10:e0140437.
   PubMed Web of Science ®Google Scholar
• Lee YH, Kim YS, Lee SN, et al. Interstitial lung change in pre-radiation therapy computed tomography is a risk factor for severe radiation pneumonitis. Cancer Res Treat. 2015;47:676–686.
   PubMed Web of Science ®Google Scholar
• Tsujino K, Hirota S, Kotani Y, et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys. 2006;64:1100–1105.
   PubMed Web of Science ®Google Scholar
• Tsujino K, Hashimoto T, Shimada T, et al. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer. J Thorac Oncol. 2014;9:983–990.
   PubMed Web of Science ®Google Scholar
• Kozower BD, Larner JM, Detterbeck FC, et al. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2003;143(Suppl.5):e369S–e399S.
   Google Scholar